Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Queensland Health
Cerilliant
Federal Trade Commission
US Department of Justice
Novartis
Deloitte
Covington

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074465

« Back to Dashboard

NDA 074465 describes TIMOLOL MALEATE, which is a drug marketed by Sandoz Inc, Akorn, Apotex Inc, Bausch And Lomb, Fdc Ltd, Fougera, Hi Tech Pharma, Pacific Pharma, Wockhardt, Mylan, Quantum Pharmics, Sandoz, Teva, Usl Pharma, and Watson Labs, and is included in thirty-eight NDAs. It is available from fifteen suppliers. There is one patent protecting this drug. Additional details are available on the TIMOLOL MALEATE profile page.

The generic ingredient in TIMOLOL MALEATE is timolol maleate. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.
Summary for 074465
Tradename:TIMOLOL MALEATE
Applicant:Akorn
Ingredient:timolol maleate
Patents:0
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074465
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 074465
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TIMOLOL MALEATE timolol maleate SOLUTION/DROPS;OPHTHALMIC 074465 ANDA Akorn, Inc. 17478-289 17478-289-11 1 BOTTLE, DROPPER in 1 CARTON (17478-289-11) > 10 mL in 1 BOTTLE, DROPPER
TIMOLOL MALEATE timolol maleate SOLUTION/DROPS;OPHTHALMIC 074465 ANDA Akorn, Inc. 17478-289 17478-289-25 1 BOTTLE, DROPPER in 1 CARTON (17478-289-25) > 2.5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.25% BASE
Approval Date:Mar 25, 1997TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Farmers Insurance
Argus Health
Baxter
QuintilesIMS
Daiichi Sankyo
Citi
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot